Veravas Launches Groundbreaking VeraBIND Technology for Ultra-Sensitive Assays and Matrix Free Sample Analysis
Revolutionary bead-based technology enables reliable biomarker detection in challenging samples, transforming clinical diagnostic performance and research workflows AUSTIN, Texas, June 20, 2023 /PRNewswire/ — Today, Veravas, a leading innovator in clinical diagnostics, announced the launch of its groundbreaking VeraBIND™ (Biomarker Isolation and N-richment for Detection) technology. With millions of assays conducted daily in clinical laboratories … Read more